57
76
Growth Score
-3 pts
Heat Score
5 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
202372
Besides Italy, where Menarini is one of the leading pharmaceutical groups, sales are mainly concentrated in Europe: Austria, Benelux,
- Elcin Ergun: Group CEOPast Role: Merck Group, Executive Vice President and Head of New Businesses
- Daryl Spinner: Vice President, Market Access and ReimbursementPast Role: Evidera, Managing Director, Real-World Value & Strategy
About the Company
Besides Italy, where Menarini is one of the leading pharmaceutical groups, sales are mainly concentrated in Europe: Austria, Benelux, France, Germany, United Kingdom, Greece, Ireland, Portugal, Spain, Turkey and Switzerland. Menarini has now reached important positions in Eastern and Central Europe where it ranks no. 6 in the total market of this
region including: Russia, Poland, Ukraine, the Baltic States, Czech Rep., Romania, Kazakhstan, Bulgaria, Belarus, Hungary, Slovak Rep., Uzbekistan, the Caucasian countries, Albania, Moldova and ex-Yugoslavia. Menarini is the leader on the market in the Baltic States, Ukraine, Belarus and ranking no. 2 in Russia and Kazakhstan.
